Member Info for Aldebaran

There has to be more than 1 offer for avacta when one actually comes.

That alone will ensure a lowball doesn't fly

Company obviously trying to release news to pump price before a placing but market isn't having it.

They should just raise now before it falls further.

That short has to close at some point can see it getting squeezed here and will be funny when it does.

No MTD found

Therapeutically significant levels of dox in tumours

Patients at end of life seeing a response even though this is only a safety trial

Cleaved dox no different thhan straigt dox

Working with more potent cytotoxins now

Platform pipeline being developed

2weekly dosing results in patients with high FAP

I mean it doesnt take a genius to work out where this is heading on a fundamental basis. and the shareprice will catch up with it.

The fact is 99.999% of people on Earth haven't even heard of Avacta including various funds. What happens when the results are broadcast as what they will be. A revolution in cancer treatment.

GSA are going to look pretty silly soon enough

Given volume of late Heights latest batch must be almost done and then SP should be free to start following the fundamental progress the company are making

Thorn.

Why would cleaved dox behave any different to straight dox?

I'll wait

Someone has to carry the can for that diastrous raise and the decision not to take more funds when it was oversubscribed only then to allow heights to dilute at 42p a few weeks later. Yes avacta might have thought the SP would be higher after the data release but again shows his lack of commercial acumen. Think everyone knows the science is outstanding and the data is is fantastic so its already priced in.

What the market wants is funding news i.e. deals and progress on that front. AS should know that but he clearly doesn't and ontop of the decision to throw money at Dx just compounds his error. Probably a great scientist but not a CEO who is going to really drive value out of this platform to the maximum benefit of shareholders which should be his primary concern. The science will take care of itself

Anyway, heights still dumping so expecting this to fall back to 38p but no lower and then should go on a nice run with the right CEO appointment and materialisztion of actual deals plus a real plan to move to the NASDAQ

A few months cash runway puts bsfa in a very poor and weak position regarding any deal they may or may not be working on. The market isn't stupid something bad is coming here.

Look at avacta the price was dropping for weeks/months as management were trying to sort financing in the background whilst assuring investors they are working on deals and have loads of optionality etc

Does that sound familiar?

Because avacta price crashed and THEN a placing was finally had at even a 30% discount to the already crashed price lol

Exact same thing is happening here if you can't see it then I feel bad for you.

My guess will be a fundraise around 2p the way this is headed. Seems unthinkable right?

Wrong.

Companies are being absolutely shafted if they need cash and BSFA is no different so be careful yall. Be careful thats all im saying

Sub optimal?

Lol

Try dosing red devil every 2 weeks and see what happens. AVA6K being doses at over 4x max allowed dose of red devil and no mtd found.

I repeat no mtd found.

Chat all you want about management and funding and cln blah blah but the science works and trial going exceptionally well.

Still expect 38p in short term but long term many pounds

Heights are in profit at 42p and above so odds on this hits 42p and then there will be a few margin calls and desperate sellers on top etc

Plus we expecting a poor update at end of month?

I see 38p needing to be hit also

An article isn't going to lift the price of hemo not now not in this market i think that's wishful thinking.

I read somewhere that when comparing avacta to hemo there was no comparison at all from a risk reward perspective. The article went on to say avacta is in a league of its own and the ceo has confirmed last week they have the holy grail in cancer treatment yet shares haven't budged. Its all about sales. Looks like avacta have to wait 2 years for sales which feels like forever but at least they are funded now for at least 2 years.

What is the cash position here at hemo looking like and when are they expecting sales?

JWBellamy perhaps you could answer as you seem to know everything about hemo and are trying to cross ramp it on other bulletin boards like your post on avacta today

It is obvious now the science works I think everyone agrees on that

So when do Avacta actually let the world know?

I imagine it will be when the 1st line patients they are treating all are seeing stable disease or tumour regression so can make a splash in the media with some human stories

When will that be ? are the 2 weekly dosed patients taking AVa6000 as a first line treatment?

Gje excellent thank you.

At 50p a share then our quarterly payment will sting but given the volume traded here it will come and go pretty quickly. That's if they haven't already been forward selling which I know they're not supposed to but neither are placings supposed to be leaked or insiders to trade etc and it happens

Gje again thanks. So if we don't get clobbered by conversion I.e. heights don't convert to shares then dump on the market how will we get clobbered financially i am really struggling to understand this cln and you seem to have a great handle on it and are willing to share as well.

Does this mean we have to pay back the money this quarter in cash if the share price is below the conversion price?

There's a lot of nonsense and arguing on this bored so useful information like you have posted us highly appreciated and refreshing. Thank you

Gje this is all very complicated but appreciate the work you have put into it.

What does it mean in simple terms tho

How do we watch presentation later is there a link

How many shares have traded since being admitted guys any clue?

Wondering when the churn will end

Years am long now m8.

MMs searching for liquidity also isn't helping

Sorry to sound callous but if patients take it for longer does that mean more profit for avacta?

Precautionary chemo they say. Wow.

Sorry to be so cold and sounding harsh it first goes without saying this is terrible news etc...

But the thing with chemo and specific the avacta chemo is that is flushes the entire body so any small little undetected tumours hugh in FAP will be targeted.

Despite other treatments advancing all the time I don't see chemo goes away especially if it can ve delivered without any severe side effects.

Kates body will be ravished by chemo bless her. Big pharma have a responsibility to buy avacta ASAP AND put multiple indications into trial immediately.

When people see what chemo has done to Kate especially if she loses her hair etc and then avacta come out with some human stories of delivering chemo without side affect then obviously this will be fantastic for the company

But goes without saying dreadful for Kate and her family